my report listening to the investor conference, page-7

re this comment: "PRR is the only company in the world doing late stage ovarian cancer trials."

I think this should be restates as: "PRR is the only company in teh world doing late stage ovarian cancer VACCINE trials".

there are any number of late stage trials that involve different therapeutic technologies. Many of these have been discussed on hotcopper at some time or other.

Other corrections would include:

- the 2018 patent applies only to Europe, not USA

- Martin indicated that he had more than enough funding for Phase IIb, but there was no mention of Phase III (which will presumably cost $100 million - it does for everyone else, and I don't know why PRR would be any different)